Nimbelink

First Analysis portfolio company NimbeLink acquired by Airgain

Venture capital / By
Airgain Inc. (Nasdaq: AIRG), a leading provider of advanced antenna technologies used to enable high performance wireless networking across a broad range of devices and markets, including consumer, enterprise and automotive, recently announced it has acquired First Analysis portfolio company NimbeLink, a leader in cellular industrial Internet of Things (IoT) solutions and services. The addition of NimbeLink’s embedded modem products and asset tracking solutions is key to Airgain’s ongoing strate

First Analysis portfolio company NimbeLink acquired by Airgain Read More »

Apixio Gfx 09122020085457

First Analysis portfolio company Apixio acquired by Centene

Venture capital / By
Centene Corp. (CNC) has acquired First Analysis portfolio company Apixio, a healthcare analytics company offering artificial intelligence technology solutions. First Analysis has a long history of researching and investing in healthcare technology companies. First Analysis Managing Director Matthew Nicklin commented, “We appreciate having had the opportunity to be part of the Apixio story. Apixio is a great example of how a strong team addressing a critical need in the healthcare ecosystem can c

First Analysis portfolio company Apixio acquired by Centene Read More »

Fortress Information Security Gfx 04082020070401

First Analysis invests in Fortress Information Security, a risk management solution provider

Venture capital / By
First Analysis, a leading venture capital investor, has made a new investment in Fortress Information Security, an information security and cyber risk mitigation company that has redefined traditional risk management. Fortress combines automation, continuous monitoring, vulnerability scanning and other powerful technology with human assets to deliver risk management solutions for critical infrastructure clients such as electric utilities.

First Analysis invests in Fortress Information Security, a risk management solution provider Read More »

Vida Sm Gfx 19042020094051

First Analysis invests in VIDA, the leader in AI-powered lung imaging analysis

Venture capital / By
First Analysis, a leading venture capital investor, has made a new investment in VIDA Diagnostics Inc. (VIDA). VIDA provides the new standard of pulmonary care by using AI-powered CT imaging software and services to aid early detection, evaluation, and treatment planning for patients with or at risk of lung diseases. First Analysis led an $11 million initial close of the Series C round to accelerate the commercialization of VIDA’s LungPrint® solution suite.

First Analysis invests in VIDA, the leader in AI-powered lung imaging analysis Read More »

Checkpointsurgical

First Analysis portfolio company Checkpoint Surgical receives FDA breakthrough designation for nerve regeneration device

Venture capital / By
First Analysis portfolio company Checkpoint Surgical, a leader in hand-held, intraoperative neurostimulation technology for nerve protection and repair, announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for the Checkpoint brief electrostimulation therapy (BEST) system.

First Analysis portfolio company Checkpoint Surgical receives FDA breakthrough designation for nerve regeneration device Read More »